Drugs · Entity Annotation Prototype (beta)

2articles mentioning drugs

2drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: B16F10 ×

B16F10

This drug is selected. Its supporting articles are shown below.

B16F102

Articles mentioning B16F10

2 articles · page 1 of 1

807 A novel approach for inhibiting the CD16a cleavage and promoting antibody-dependent cellular cytotoxicity against tumors

jitc · abstract · 2025-11-04 · 1 matching annotations

77.2%

F9H4 cetuximab necitumumab B16F10 protease inhibitors lung cancer

…able engagement by tumor cell-opsonizing antibodies. Therefore, F9H4 represents a new opportunity in cancer immunotherapy research.E…

895 The lack of abscopal effects with oncolytic virus immunotherapy is due to a dominant anti-viral – rather than anti-cancer – T cell response

jitc · abstract · 2025-11-04 · 1 matching annotations

75.3%

Talimogene laherparepvec talimogene laherparapvec pembrolizumab B16F10 melanoma Massachusetts General Hospital MGH